* This is the Professional Version. *
Atypical moles (AM) are melanocytic nevi with irregular and ill-defined borders, variegated colors usually of brown and tan tones, and macular or papular components. They have an increased risk of melanoma. Management is by close clinical monitoring and biopsy of highly atypical or changed lesions. Patients should reduce sun exposure and conduct regular self-examinations for new moles or changes in existing ones.
AM are nevi with a slightly different clinical and histologic appearance (disordered architecture and atypia of melanocytes). Patients with AM are at increased risk of melanoma; risk increases as the number of AM increases and as sun exposure increases. Some patients have only one or a few AM; others have many.
The propensity to develop AM may be inherited (autosomal dominant) or sporadic without apparent familial association. Familial atypical mole–melanoma syndrome refers to the presence of multiple AM and melanoma in ≥ 2 1st-degree relatives. These patients are at markedly increased risk (25 times) of melanoma.
Although clinical findings suggest the diagnosis of AM (see Characteristics of Atypical vs Typical Moles), clinical differentiation between atypical nevi and melanoma can be difficult; biopsy of the worst-appearing lesions should be done to establish the diagnosis and to determine the degree of atypia.
Characteristics of Atypical vs Typical Moles
Patients with multiple AM and a personal or family history of melanoma should be examined regularly (eg, yearly for family history of melanoma, more often for personal history of melanoma). Some dermatologists do imaging of the skin using a hand-held instrument (dermoscopy) to see structures not visible to the naked eye. Dermoscopy can reveal certain high-risk characteristics.
If desired, atypical moles can be removed by excision or shaving. Atypical moles may warrant removal if a patient has a high-risk history (eg, personal or family history of melanoma), cannot guarantee close follow-up, or if the mole has high-risk dermatoscopic findings or is in a location that makes monitoring the lesion for changes difficult or impossible for the patient.
Patients with AM should avoid excessive sun exposure and use sunscreens (see Sunscreens). Patients who are vigilant about sun protection should be counseled to take sufficient supplemental vitamin D. Also, they should be taught self-examination to detect changes in existing moles and to recognize features of melanomas. Full-body photography may help detect new nevi and monitor existing nevi for changes. Regular follow-up examinations are recommended.
If patients have a history of melanoma (whether developing from AM or de novo) or other skin cancers, 1st-degree relatives should be examined. Patients who are from melanoma-prone families (ie, ≥ 2 1st-degree relatives with cutaneous melanomas) have a high lifetime risk of developing melanomas. The entire skin (including the scalp) of members of an at-risk family should be examined at least once to determine risk and needed follow-up.
Risk of melanoma is higher if patients have increased numbers of AM, increased sun exposure, or familial atypical mole–melanoma syndrome.
Because clinical differentiation from melanoma can be difficult, biopsy the worst-appearing AMs.
Closely follow patients with AM, particularly those at higher risk of melanoma, and do full-body photography.
Recommend sun protection (with supplemental vitamin D) and self-examination for high-risk changes.
Do full-body examinations of all 1st-degree relatives of patients who have melanoma.
* This is a professional Version *